DECIPHERA PHARMACEUTICALS IN

CUSIP: 24344T101 Class: Common Stock

GSA CAPITAL PARTNERS LLP's Holding History (CIK: 0001362033)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 52,119 Value ($000) $1 Avg Close — Range —
Q4 2023
Shares 132,130 Value ($000) $2 Avg Close — Range —
Q3 2023
Shares 162,699 Value ($000) $2 Avg Close — Range —
Q2 2023
Shares 120,095 Value ($000) $2 Avg Close — Range —
Q1 2023
Shares 102,231 Value ($000) $2 Avg Close — Range —
Q4 2022
Shares 68,289 Value ($000) $1 Avg Close — Range —
Q3 2022
Shares 14,247 Value ($000) $264 Avg Close — Range —
Q2 2022
Shares 24,923 Value ($000) $328 Avg Close — Range —
Q1 2022
Shares 18,713 Value ($000) $173 Avg Close — Range —
Q4 2021
Shares 15,388 Value ($000) $150 Avg Close — Range —
Q3 2021
Shares 60,550 Value ($000) $2,057 Avg Close — Range —
Q4 2020
Shares 4,890 Value ($000) $279 Avg Close — Range —
Q1 2020
Shares 9,548 Value ($000) $393 Avg Close — Range —